Quantcast
Don't Miss

GenVec cuts loss, grows revenue in 1Q

GenVec Inc., of Gaithersburg, a biopharmaceutical company developing novel gene-based drugs and vaccines, reported a first-quarter net loss of $1 million, or 7 cents per diluted share, on revenue of $2.1 million, compared to a net loss of $3 million, or 24 cents per diluted share, on revenue of $1.2 million for the year-ago period.

Print, Digital & Mobile

Monthly Autorenew
$9.99
(special offer!)

----------
3 Months
$84.00

----------
6 Months
$162.00

----------
1 Year
$269.00


Digital & Mobile Only

1 Year
$169.00

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top